OS Therapies Incorporated (OSTX)
NYSEAMERICAN: OSTX · Real-Time Price · USD
1.510
+0.180 (13.53%)
Apr 2, 2025, 9:30 AM EST - Market open

OS Therapies Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 2020
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20
Net Income
-8.88-7.79-6.25-7.42-6.03
Depreciation & Amortization
00000
Other Amortization
1.432.651.152.070.27
Stock-Based Compensation
0.27----
Other Operating Activities
0.030.120.360.372.38
Change in Accounts Payable
-1.051.350.220.860
Change in Other Net Operating Assets
0.920.670.73-0.280.96
Operating Cash Flow
-7.28-3.01-3.79-4.4-2.41
Capital Expenditures
----0.01-0
Other Investing Activities
-00.230.210.16
Investing Cash Flow
-00.230.20.16
Short-Term Debt Issued
0.25----
Long-Term Debt Issued
1.53.163.822.953.6
Total Debt Issued
1.753.163.822.953.6
Short-Term Debt Repaid
-0.25----
Long-Term Debt Repaid
-----0.12
Total Debt Repaid
-0.25----0.12
Net Debt Issued (Repaid)
1.53.163.822.953.48
Issuance of Common Stock
5.23---0
Other Financing Activities
--0.28-0.170.1-
Financing Cash Flow
12.782.873.653.053.48
Net Cash Flow
5.49-0.130.09-1.151.22
Free Cash Flow
-7.28-3.01-3.79-4.41-2.42
Free Cash Flow Per Share
-0.59-0.28-0.38-0.44-0.29
Cash Interest Paid
---0.010.01
Levered Free Cash Flow
-8.841.31-0.2-0.97-
Unlevered Free Cash Flow
-8.980.82-0.22-1.43-
Change in Net Working Capital
4.73-3.53-2.56-1.6-
Updated Nov 15, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q